Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macro- and microvascular responses to LPS and exenatide
NL-OMON60127Phase 1Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Feb 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1 trial of exenatide and lipopolysaccharide endotoxin in cardiac morbidity and metabolic syndrome (MS), sponsored by Centre for Human Drug Research. Started Feb 2025; status: completed.
02
Drugs
exenatidelipopolysaccharide endotoxin
03
Conditions
cardiac morbiditymetabolic syndrome (MS)
Beyond the preview
Go deeper on NL-OMON60127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60127.